FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986833841> ?p ?o ?g. }

• W1986833841 endingPage "47" @default.
• W1986833841 startingPage "42" @default.
• W1986833841 abstract "Irinotecan and raltitrexed are active against advanced colorectal cancer, act through different mechanisms, and have non-overlapping toxicity profiles. In vitro studies have shown a schedule-dependent synergism between both drugs. The aim of this multicenter study was to determine the maximum tolerated dose (MTD) of this combination. Patients with 5-fluorouracil-refractory, advanced colorectal cancer were eligible. Dose escalation consisted of irinotecan (250-350 mg/m(2) as a 60-min infusion) in combination with a fixed dose of raltitrexed (3 mg/m(2) as a 15-min infusion, 1 h after irinotecan). Courses were repeated every 21 days. Three to 6 patients were to be included at each dose level. Dose limiting (NCI-CTC grade 3-4) toxicities (DLT) were assessed during the first 2 cycles. Thirteen patients were recruited (4, 3 and 6 in levels I, II and III, respectively). Main toxicity was diarrhea and asthenia, whereas myelotoxicity was mild. At level III, 2/6 patients experienced DLT (grade 4 diarrhea and neutropenia). The MTD was not reached, but further dose escalation was not attempted. Among 12 patients with measurable disease, 2 partial responses were observed for an overall response rate of 17%. The combination of single-agent full doses of irinotecan (350 mg/m(2)) and raltitrexed (3 mg/m(2)) in a 3-weekly schedule is feasible, with mild toxicity and a promising clinical activity. Diarrhea is the DLT, but it is not more common or severe than that described with irinotecan alone." @default.
• W1986833841 created "2016-06-24" @default.
• W1986833841 creator A5004715654 @default.
• W1986833841 creator A5004936555 @default.
• W1986833841 creator A5028793195 @default.
• W1986833841 creator A5038621092 @default.
• W1986833841 creator A5039586495 @default.
• W1986833841 creator A5060170484 @default.
• W1986833841 creator A5072621187 @default.
• W1986833841 creator A5076806829 @default.
• W1986833841 date "2002-01-01" @default.
• W1986833841 modified "2023-09-26" @default.
• W1986833841 title "Multicenter Phase I Study of Irinotecan plus Raltitrexed in Patients with 5-Fluorouracil-Refractory Advanced Colorectal Cancer" @default.
• W1986833841 cites W1832060645 @default.
• W1986833841 cites W1835830368 @default.
• W1986833841 cites W1927999720 @default.
• W1986833841 cites W1952371628 @default.
• W1986833841 cites W1979300931 @default.
• W1986833841 cites W2006824814 @default.
• W1986833841 cites W2010991676 @default.
• W1986833841 cites W2056131235 @default.
• W1986833841 cites W2096122707 @default.
• W1986833841 cites W2106482770 @default.
• W1986833841 cites W2112447448 @default.
• W1986833841 cites W2118310385 @default.
• W1986833841 cites W2119270435 @default.
• W1986833841 cites W2121368761 @default.
• W1986833841 cites W2128447158 @default.
• W1986833841 cites W2167805334 @default.
• W1986833841 cites W2272757036 @default.
• W1986833841 cites W2314927739 @default.
• W1986833841 doi "https://doi.org/10.1159/000065719" @default.
• W1986833841 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12187070" @default.
• W1986833841 hasPublicationYear "2002" @default.
• W1986833841 type Work @default.
• W1986833841 sameAs 1986833841 @default.
• W1986833841 citedByCount "6" @default.
• W1986833841 countsByYear W19868338412013 @default.
• W1986833841 countsByYear W19868338412023 @default.
• W1986833841 crossrefType "journal-article" @default.
• W1986833841 hasAuthorship W1986833841A5004715654 @default.
• W1986833841 hasAuthorship W1986833841A5004936555 @default.
• W1986833841 hasAuthorship W1986833841A5028793195 @default.
• W1986833841 hasAuthorship W1986833841A5038621092 @default.
• W1986833841 hasAuthorship W1986833841A5039586495 @default.
• W1986833841 hasAuthorship W1986833841A5060170484 @default.
• W1986833841 hasAuthorship W1986833841A5072621187 @default.
• W1986833841 hasAuthorship W1986833841A5076806829 @default.
• W1986833841 hasConcept C121332964 @default.
• W1986833841 hasConcept C121608353 @default.
• W1986833841 hasConcept C126322002 @default.
• W1986833841 hasConcept C142424586 @default.
• W1986833841 hasConcept C143998085 @default.
• W1986833841 hasConcept C2776694085 @default.
• W1986833841 hasConcept C2777063308 @default.
• W1986833841 hasConcept C2779268555 @default.
• W1986833841 hasConcept C2779802037 @default.
• W1986833841 hasConcept C2780259306 @default.
• W1986833841 hasConcept C2780456651 @default.
• W1986833841 hasConcept C2780962732 @default.
• W1986833841 hasConcept C29730261 @default.
• W1986833841 hasConcept C31760486 @default.
• W1986833841 hasConcept C526805850 @default.
• W1986833841 hasConcept C71924100 @default.
• W1986833841 hasConcept C87355193 @default.
• W1986833841 hasConcept C90924648 @default.
• W1986833841 hasConceptScore W1986833841C121332964 @default.
• W1986833841 hasConceptScore W1986833841C121608353 @default.
• W1986833841 hasConceptScore W1986833841C126322002 @default.
• W1986833841 hasConceptScore W1986833841C142424586 @default.
• W1986833841 hasConceptScore W1986833841C143998085 @default.
• W1986833841 hasConceptScore W1986833841C2776694085 @default.
• W1986833841 hasConceptScore W1986833841C2777063308 @default.
• W1986833841 hasConceptScore W1986833841C2779268555 @default.
• W1986833841 hasConceptScore W1986833841C2779802037 @default.
• W1986833841 hasConceptScore W1986833841C2780259306 @default.
• W1986833841 hasConceptScore W1986833841C2780456651 @default.
• W1986833841 hasConceptScore W1986833841C2780962732 @default.
• W1986833841 hasConceptScore W1986833841C29730261 @default.
• W1986833841 hasConceptScore W1986833841C31760486 @default.
• W1986833841 hasConceptScore W1986833841C526805850 @default.
• W1986833841 hasConceptScore W1986833841C71924100 @default.
• W1986833841 hasConceptScore W1986833841C87355193 @default.
• W1986833841 hasConceptScore W1986833841C90924648 @default.
• W1986833841 hasIssue "1" @default.
• W1986833841 hasLocation W19868338411 @default.
• W1986833841 hasLocation W19868338412 @default.
• W1986833841 hasOpenAccess W1986833841 @default.
• W1986833841 hasPrimaryLocation W19868338411 @default.
• W1986833841 hasRelatedWork W1970193197 @default.
• W1986833841 hasRelatedWork W1986833841 @default.
• W1986833841 hasRelatedWork W2027936171 @default.
• W1986833841 hasRelatedWork W2031049975 @default.
• W1986833841 hasRelatedWork W2032467083 @default.
• W1986833841 hasRelatedWork W2037756952 @default.
• W1986833841 hasRelatedWork W2059006210 @default.
• W1986833841 hasRelatedWork W2111126631 @default.
• W1986833841 hasRelatedWork W2111292971 @default.

• next